Twist Bioscience
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $118,376 | $110,715 | $103,698 | $99,009 |
Gross Profit | 62,454 | 57,122 | 53,972 | 50,837 |
EBITDA | -27,962 | -32,244 | -26,706 | -20,878 |
EBIT | -34,740 | -38,658 | -32,900 | -26,882 |
Net Income | -35,051 | -44,021 | -30,507 | -27,138 |
Net Change In Cash | 118,376 | 110,715 | 103,698 | 99,009 |
Free Cash Flow | -8,548 | -25,546 | -34,788 | -24,241 |
Cash | 117,436 | 122,670 | 148,591 | 183,049 |
Basic Shares | 62,403 | 61,702 | 61,080 | 60,424 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $376,572 | $312,974 | $245,109 | $203,565 |
Gross Profit | 191,002 | 133,349 | 89,729 | 84,235 |
EBITDA | -52,098 | -176,705 | -174,151 | -247,046 |
EBIT | -76,951 | -208,137 | -203,461 | -249,021 |
Net Income | -77,670 | -208,726 | -204,618 | -217,863 |
Net Change In Cash | 376,572 | 312,974 | 245,109 | 203,565 |
Cost of Revenue | -86,781 | |||
Free Cash Flow | -75,632 | -69,170 | -170,253 | -226,242 |
Cash | 183,049 | 226,316 | 286,470 | 378,687 |
Basic Shares | 59,808 | 58,016 | 56,885 | 53,885 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.56 |
2026-03-31 | -$0.60 |
2025-12-31 | -$0.50 |
2025-09-30 | -$0.45 |